Omeprazole Capsules

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D224D0004

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents5
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the procurement of Omeprazole Capsules. This notice, identified by procurement number SPE2D224D0004, announces Modification 0005, which exercises the second-year option of the existing contract. The contract remains active and is classified under NAICS Code 325412, corresponding to Pharmaceutical Preparation Manufacturing, with the product service code 6505, indicating drugs and biologicals. The primary objective of this procurement is to ensure the continued supply of Omeprazole Capsules, a pharmaceutical product essential for troop support and medical readiness. By exercising the second-year option, DLA Troop Support demonstrates its commitment to maintaining a reliable source of this medication, supporting the health and operational effectiveness of Department of Defense personnel. The scope of the contract encompasses the manufacturing and delivery of Omeprazole Capsules, adhering to stringent quality and regulatory standards expected in federal pharmaceutical procurement. Contractors are expected to provide consistent, high-quality deliverables throughout the contract lifecycle, ensuring timely fulfillment and compliance with all applicable requirements. DLA Troop Support, as the contracting entity, is a federal office within the Defense Logistics Agency, responsible for sourcing and supplying medical and pharmaceutical products to military and defense agencies. The primary point of contact for this contract is Courtney Hunter-Stangler, who can be reached at [email protected] or 215-737-6845. A secondary contact, Jason Wray, is available at [email protected] or 215-737-0614, providing additional support for inquiries related to the contract. This procurement is managed through the SAM.gov portal, with the opportunity ID 738814b882234e98ba14d4f33b3d2afa and further details accessible via the provided notice URL. The notice remains active as of the post date, September 2, 2026, and includes five attachments for reference. Contractors interested in this opportunity should note that it is an award notice for a contract modification, specifically the exercise of an option year, rather than a new solicitation. The requirements and deliverables are consistent with pharmaceutical manufacturing and supply for federal agencies, and the contract is governed by the standards and regulations applicable to the Department of Defense and DLA Troop Support. No set-aside requirements or special considerations are specified in the notice. Overall, this contract represents a stable, ongoing opportunity for qualified pharmaceutical manufacturers to support the Department of Defense’s medical supply chain, with clear expectations for quality, reliability, and compliance throughout the contract period.